肝移植术后早期严重肝内胆汁淤积的相关因素分析
Risk factors of severe intrahepatic cholestasis during early period after liver transplantation
-
摘要: 目的 探讨同种异体原位肝移植术后早期发生严重肝内胆汁淤积的危险因素。方法 回顾性分析2004年8月至2011年2月南方医科大学南方医院收治的225例同种异体原位肝移植患者的临床资料,根据是否发生严重肝内胆汁淤积将患者分为阳性组(60例)和阴性组(165例),对两组患者术前、术中、术后各项指标进行比较分析。计量资料采用t检验,不符合正态分布及方差齐性的计量资料和等级资料采用Wilcoxon秩和检验,计数资料采用χ2检验,多因素分析采用Logistic回归模型。结果 术前阳性组患者肝硬化比例、肝性脑病积分、腹腔积液积分、国际标准化比值、PT、TBil、AST较阴性组高,两组比较,差异有统计学意义(χ2=6.09,Z=2.22,2.60,2.46,2.84,4.81,3.42,P<0.05);而血清中Alb、Na+、K+、Hb、 PLT比阴性组低,两组比较,差异有统计学意义(t=2.10,4.97,Z=2.49,t=3.51,Z=3.66,P<0.05)。术中阳性组患者供、受者血型相容的比例、供肝轻度脂肪化比例、冷缺血时间、相对热缺血时间、术中出血量、输注RBC量、输注PLT量、输注冷沉淀量较阴性组高,两组比较,差异有统计学意义(χ2=4.29,13.11,Z= 2.45,2.61,3.75,3.20,2.89,3.95,P<0.05)。术后阳性组患者急性排斥、肝动脉血栓、肺部感染、血行感染、真菌感染、巨细胞病毒感染发生率比阴性组高,两组比较,差异有统计学意义(χ2 =9.87,4.91,8.21, 6.29,3.92,9.26,P<0.05)。多因素分析发现术前TBil>51.3μmol/L、供肝轻度脂肪化、术中输注冷沉淀量、术后急性排斥、肝动脉血栓、术后肺部感染、血行感染、巨细胞病毒感染是发生严重肝内胆汁淤积的独立危险因素(OR=15.82,7.99,2.88,3.03,53.20,3.34,4.11,3.22,P<0.05);而在术前较高的PLT、较长的PT患者术后发生严重肝内胆汁淤积的几率较小(OR=0.33,0.25,P<0.05)。术后6个月阳性组和阴性组病死率分别为41.7%(25/60)和19.4%(32/165),两组比较,差异有统计学意义(χ2 =11.54,P< 0.05)。结论 纠正受者术前不良的临床因素;术后积极控制感染和抗排斥反应可降低原位肝移植患者术后早期严重肝内胆汁淤积的发生率,并有可能改善早期预后。Abstract:
Objective To investigate the risk factors of severe intrahepatic cholestasis during early period after liver transplantation. Methods The clinical data of 225 patients who received orthotopic liver transplantation at the Nanfang Hospital of Southern Medical University from August 2004 to February 2011 were retrospectively analyzed. All patients were divided into positive group (60 patients with intrahepatic cholestasis) and negative group (165 patients without intrahepatic cholestasis). Preoperative, intraoperative and postoperative factors of the 2 groups were compared via t test, chi square test, Wilcoxon test or Logistic regression analysis. Results The proportion of patients with hepatic cirrhosis, hepatic encephalopathy integral, ascites integral, international normalized ratio, and the levels of prothrombin time (PT), total bilirubin (TBil), aspartate aminotransferase of the positive group before operation were significantly higher than those in the negative group (χ 2=6.09, Z= 2.22, 2.60, 2.46, 2.84, 4.81, 3.42, P <0.05),while the levels of albumin, Na +, K +, hemoglobin, platelet (PLT) of the positive group in the operation were significantly higher than those in the negative group ( t=2.10, 4.97, Z=2.49, t=3.51, Z=3.66, P <0.05). The ratio of compatible blood type of the donors and recipients, ratio of fatty liver graft, cold ischemia time, relative warm ischemia time, intraoperative blood loss, intraoperative transfusion of red blood cells, PLT, and cryoprecipitate of the positive group after the operation were significantly higher than those in the negative group (χ 2=4.29, 13.11, Z=2.45, 2.61, 3.75, 3.20, 2.89, 3.95, P < 0.05) . The incidences of acute rejection, hepatic artery embolism, pulmonary infection, bacteraemia, fungal infection and cytomegalovirus (CMV) infection were significantly higher than those in the negative group (χ 2= 9.87, 4.91, 8.21, 6.29, 3.92, 9.26, P <0.05). The Results of multivariate analysis revealed that preoperative level of TBil>51.3 μmol/L, fatty of the liver graft, intraoperative transfusion of cryoprecipitate, postoperative acute rejection, hepatic artery embolism, postoperative pulmonary infection, bacteraemia, CMV infection were independent risk factors of severe inrahepatic cholestasis ( OR=15.82, 7.99, 2.88, 3.03, 53.20, 3.34, 4.11, 3.22, P <0.05). The incidence of severe intrahepatic cholestasis was significantly lower in patients with higher level of PLT and longer PT ( OR=0.33, 0.25, P <0.05). The mortality rates of the positive group and negative group at 6 months after the operation were 41.7%(25/60) and 19.4%(32/165), and the mortality rate of the positive group was significantly higher (χ 2=11.54, P <0.05). Conclusion Correction of poor clinical status before liver transplantation, reinforcement of infection control and anti rejection may reduce the incidences of complications and decrease the associated early mortality.